Is the neurosurgical treatment of Parkinson's disease still indicated? 1980

J Siegfried

Long-term results of the medical treatment of Parkinson's disease are somewhat disappointing despite an increased longevity and a more prolonged functional ability. The appearance of iatrogenic side-effects lead some authors to withhold levodopa until severity of symptoms really warrants its use. In this context the place of neurosurgery is re-evaluated. With specific indications a correctly performed stereotactic operation is still the best therapy available capable of suppressing tremor, iatrogenic hyperkinesias and rigidity and must be considered when these symptoms incapacitate the functional and social life of the patient.

UI MeSH Term Description Entries
D008134 Long-Term Care Care over an extended period, usually for a chronic condition or disability, requiring periodic, intermittent, or continuous care. Care, Long-Term,Long Term Care
D010300 Parkinson Disease A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75) Idiopathic Parkinson Disease,Lewy Body Parkinson Disease,Paralysis Agitans,Primary Parkinsonism,Idiopathic Parkinson's Disease,Lewy Body Parkinson's Disease,Parkinson Disease, Idiopathic,Parkinson's Disease,Parkinson's Disease, Idiopathic,Parkinson's Disease, Lewy Body,Parkinsonism, Primary
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000978 Antiparkinson Agents Agents used in the treatment of Parkinson's disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists. Antiparkinson Drugs,Antiparkinsonian Agents,Antiparkinsonians,Agents, Antiparkinson,Agents, Antiparkinsonian,Drugs, Antiparkinson

Related Publications

J Siegfried
March 2004, MMW Fortschritte der Medizin,
J Siegfried
July 1970, Journal of neurosurgical nursing,
J Siegfried
October 1958, Belgisch tijdschrift voor geneeskunde,
J Siegfried
May 1968, Archiv fur orthopadische und Unfall-Chirurgie,
J Siegfried
December 2001, Journal francais d'ophtalmologie,
J Siegfried
July 1974, Deutsche medizinische Wochenschrift (1946),
J Siegfried
August 2009, European journal of trauma and emergency surgery : official publication of the European Trauma Society,
J Siegfried
January 2002, Movement disorders : official journal of the Movement Disorder Society,
Copied contents to your clipboard!